Approval · Notice of Compliance 33017 · 2024
SKYRIZI: Notice of Compliance 33017
Issued April 5, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33017
- Date
- April 5, 2024
- Company
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New presentation
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SKYRIZI | 02546922 | Approved |
Medicinal ingredients
- RISANKIZUMAB 90 MG per ML